Restore by Rewalk Robotics is a battery-powered, lightweight soft exosuit, for the rehabilitation of stroke patients with limited walking function. It is part of the Rewalk exoskeleton systems.
Everything you need to know about the features and benefits of the ReStore exoskeleton for gait training in stroke by ReWalk for restricted foot and ankle). need to know.
This therapy method is unique for rehabilitation clinics and the like, as it allows both supported dorsiflexion and supported plantar flexion for functional gait training of stroke patients.
ReStore Rewalk supports plantar flexion and dorsiflexion of the patient's restricted foot and ankle joint, resulting in improved force transmission. Rewalk Restore coordinates plantar flexion and dorsiflexion support of the patient's restricted foot and ankle joint, optimizing force transmission.
Sensors on the patient's shoes analyze movement and control the timing of support. A trained therapist can monitor key parameters, adjust the level of support, change/select modes, and record standardized gait school assessments.
ReStore combines gentle components with supportive plantar flexion and dorsiflexion to adapt to the patient's individual gait pattern. ReStore is an innovative design that supports natural movements to facilitate functional gait training for patients. Real-time analytics and customizable levels of support allow therapists to optimize therapy sessions as well as track their patients' progress.
The system controls the movement by small changes of the center of gravity and initiates a natural gait. The system controls the movement by small changes of the center of gravity and a natural gait is initiated. In order to use an exoskeleton, the ability to move hands and shoulders as well as walk with canes must be present. Healthy bone density and a healthy cardiovascular system are also prerequisites.
The 6.0 system is adapted to the user's body dimensions and individually manufactured. The high accuracy of fit significantly improves system function, safety and joint alignment. Walking speed In clinical trials with the ReWalk system, users achieved speeds of up to 0.71 m/s (2.6 km/h). This makes ReWalk 6.0 the fastest exoskeleton on the market. Product design ReWalk 6.0 no longer requires a backpack to carry the power supply and control electronics. This not only relieves the wearer's shoulders, but also offers increased freedom of movement in addition to more choice in daily wear. The sleek, new design of the straps and padding allows users to put on and take off the system more easily and quickly.
ReStore is a lightweight soft exo-suit powered by rechargeable batteries and specifically designed for the rehabilitation of stroke patients with limited gait function. It is a pioneering therapy option for gait training in stroke patients.
Functionality The unique design with flexible components allows ReStore to promote natural movements while supporting plantar flexion and dorsiflexion. In doing so, the Exo-Suit adapts individually to each patient's gait pattern to provide effective functional gait training.
Versatility Thanks to the individual adjustment options and compatibility with additional aids, ReStore offers a wide range of applications in gait therapy for patients. The support can be adapted to the needs and progress of the individual patient.
Data-driven therapy Through real-time analysis and the ability to customize levels of support, ReStore enables therapists to optimally adjust therapy sessions. In addition, patient progress can be tracked to ensure targeted and efficient rehabilitation.
ReStore has revolutionized the way post-stroke gait training is delivered to people with lower limb disabilities. As a lightweight powered exo-suit, it offers a soft design that allows natural movements and adapts to the patient's individual gait pattern. This promotes functional gait training and supports rehabilitation.
Thanks to ReStore's flexible support features and its compatibility with complementary assistive devices, the Exo suit is highly versatile and suitable for a wide range of patients undergoing gait rehabilitation. It offers individualized levels of support that can be adjusted in real time, as well as a feedback system that allows therapists to optimize sessions and track patient progress using data-based analytics.
ReStore's adaptability allows patients to regain and improve their gait pattern naturally. The suit supports plantar flexion and dorsiflexion, which plays an important role in lower limb movement coordination and stability. With the support of ReStore, patients can gradually regain their walking abilities and improve their independence in everyday life.
Another advantage of ReStore is its ability to provide valuable information to therapists. With real-time feedback and the ability to adjust support levels, therapists can optimize treatment sessions and closely monitor patient progress. This enables personalized rehabilitation and helps achieve the best results.
Overall, ReStore has taken post-stroke gait training to a new level. With its lightweight and adaptable design, the exo-suit enables effective rehabilitation and promotes patient progress. By combining technology and human expertise, ReStore offers hope and opportunity for people with lower limb disabilities to restore their mobility and quality of life.
The ReStore Exosuit is intended for use in a clinical setting. It has received both CE and FDA approval for use. The ReStore Exo-Suit was developed in collaboration with the Wyss Institute at Harvard, first announced more than three years ago: (Wyss Institute and ReWalk Robotics Form Collaboration, May 2016) This joint effort combines the Wyss Institute's technological expertise in soft exoskeletons (exosuits) with ReWalk's deep knowledge of clinician engagement. The ReStore exosuit aims to enable gait training after stroke with a solution that is lighter and more maneuverable than a rigid exoskeleton powered by the lower body. The Exosuit is a data-driven powered gait rehabilitation device designed to facilitate functional gait training. It is also said to be significantly less expensive than a rigid frame exoskeleton. The ReStore Exo-Suit is the first soft-power exoskeleton to be approved by the FDA, and it also has a CE mark for distribution in Europe. FDA clearance is based on a multi-center clinical trial, with data generated used for the successful 510(k) submission.
The ReStore exoskeleton from ReWalk is a medical device for gait training for stroke patients with limited foot and ankle joints. It can be used both indoors and outdoors and focuses on the lower body and hips to support the legs and trunk. The main movements that can be performed with the exoskeleton are standing, walking and running. It is suitable for mobile rehabilitation and weighs a total of 30 kg. Thanks to the integration of artificial intelligence, it can be adapted to users with a height of 160 to 185 cm. It also allows sitting on a chair. The maximum temperature of use is 40 degrees Celsius. The retail price of the exoskeleton is 85,000 euros net, and it can be purchased in both the U.S. and Europe without requiring a minimum purchase quantity. Maintenance of the device is required, and it has FDA approval and CE marking. An instruction manual is available, and a trial package is offered by the manufacturer. The exoskeleton provides support for one leg or both legs and has a battery charge time of 4 hours with a shelf life of 3 hours. It is manufactured by the manufacturer in the USA.
ReStore by ReWalk Robotics is a more cost-effective and space-saving system compared to other systems in robotic gait therapy. ReStore by ReWalk Robotics is an efficient system that a trained physiotherapist can use throughout the entire therapy session.
ReStore is available for sale to rehabilitation facilities in Europe and the U.S., as well as other regions worldwide, depending on country-specific regulatory requirements.
In May 2016, there was a ruling at the state level that if an exoskeleton is purchased, it will be covered by cost recovery.
Specifications according to manufacturer Walking upright Accessing buildings and areas without ramps Performing activities while standing Getting to elevated objects More independence Conversations at eye level Participating in events while standing (reception, presentation, etc.) Going for a walk Tested
Health benefits: Effects on bone density Reduced body fat Improved balance and posture Improved cardiorespiratory function Improved bowel/bladder function Improved sitting posture Reduced pain and fatigue Reduced spasticity
Can't find the answer to your question? Contact us.
ReStore is used in rehab, specifically for stroke patients with limited walking function, primarily foot and joint problems, but with residual mobility.
Former President Obama took a close look at ReWalk's exoskeletons in the field and was impressed. ReWalk Robotics was founded in 2001 and remains the only manufacturer of exoskeletons with FDA approval in the U.S. for both home and rehabilitation use. Rewalk Robotics has received a total of $ 210.6 million in 16 rounds of funding. The latest funding was raised on September 27, 2021, in a post-IPO equity round. Rewalk Robotics is registered under the ticker NASDAQ:RWLK. The company's stock opened at 12.00 $ on September 12, 2014. Rewalk Robotics is funded by 8 investors. Timwell Corporation and Kreos Capital are the most recent investors.
Image sources: All images and graphics are copyrighted and property of ©.
ReWalk Robotics Ltd.